Dr. Lisa Florence is the lead investigator for the following clinical trials currently available at the Swedish Medical Center:
Prospective, multi-center, observational registry study to determine if enrollment in a regional kidney paired donor exchange program improves the overall rate of kidney transplantation in sensitized patients, and sensitized patients undergoing desensitization treatments
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor
Florence LS, Feng S, Foster CE 3rd, Fryer JP, Olthoff KM, Pomfret E, Sheiner PA, Sanfey H, Bumgardner GL. Academic careers and lifestyle characteristics of 171 transplant surgeons in the ASTS. Am J Transplant. 2011 Feb;11(2):261-71.
Marks WH, Florence LS, Chapman PH, Precht AF, Perkinson D. Should true morbidly obese patients be denied kidney transplantation. American Journal of Surgery, 167(5):635-8, 2004
Florence LS, Marks WH, Howard DR. Chapman PH. Lieberman J, Perkinson D. Atgam induction with sequential mycophenolate mofetil (MMF) decreases the incidence of early allograft rejection in cadaveric renal transplants. Transplantation Proceedings, 29. 1997.
Lieberman JM. Marks WHo Stuart FP. Abecassis MM. Florence LS and Kaufman D. Co-monitoring serum anodal trypsinogen, serum amylase. and serum creatinine accurately differentiates rejection from other causes of allograft dysfunction after simultaneous pancreas-kidney transplantation. Transplantation Proceedings, 29. 676-677,1997.
Marks WH, Ma Y, Yirdaw G, and Florence LS. Asialogalactoprotein-asialogalactoprotein receptor (AGP-AGPr) interaction is an important mechanism for the uptake of FK506 by hepatocytes. Transplantation: 63.293-298. 1997.
Marks WH, Florence LS, Lieberman J, Chapman P, Howard D, Roberts PP and Perkinson D. Successfully treated invasive pulmonary Aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation 61(12): 1771-1774. 1996.
Florence LS, Jiang GL. Ang KK. Stepkowski SM. and Kahan 80. In vitro analysis of T cell mediated cytotoxicity displayed by rat heart allograft recipients rendered unresponsive by total lymphoid irradiation and extracted donor antigen. Transplantation, 49(2): 436-444, 1990.
Florence LS, Ito T, Ang KK, Kahan BD, et al. The synergistic effect of total lymphoid irradiation with extracted donor alloantigen in inducing transplantation unresponsiveness. Transplantation, 47(1): 156-162. 1989.
Luna G, Florence LS, Johansen D. Hepatocellular carcinoma: A 5-year institutional experience. American Journal of Surgery, 149(5): 591-594, 1985.
Precht AF, Lieberman JM, Florence LS, Nakamoto LA, Marks WHo Right renal vein elongation using stapler reconstruction for deceased donor kidneys. ATe, Boston, 2009.
Florence LS. Christensen LL, Wolfe, RA. Galloway J, Distant D. Hull D. Kauffman M, Sung RS. Machine preservation (MP) by locale on the risk for delayed graft function (DGF) and graft failure (GF): an analysis of transplanted deceased donor (DO) kidneys in the United States over a two year period. American Transplant Congress. May 2007.
McBride MA, Florence LS. Anderson K, Kauffman, HM. Donors with a history of drug use are an underutilized source of kidneys. American Transplant Congress. May 2007.
Kauffman HM. Taranto SE, McBride MA, Florence LS. Regional variations in the reported reasons for discarding recovered kidneys. American Transplant Congress, May 2007.
Christensen LL, Wolfe RA, Distant DA. Florence LS, Hull 0 , Sung RS. Organ Procurement Organization (OPO) pumping practices and associations with kidney discard. American Transplant Congress, May 2007.
Kauffman HM. McBride MA, Anderson K. and Florence LS. Deceased donor with a history of drug use: an underused source of extra-renal organs. American Transplant Congress, May 2007.
Goldberg SZ. Florence LS, Eschbach J, Tickman R, Skogerboe KJ , Myerson 0, Marks WHo A case of metastatic breast cancer transplanted along with a kidney and complete remission after rejection of the transplant. American Society of Transplant Surgeons Winter Meeting. January 2003.
Florence LS, Howard DR, Chapman PH, Perkinson OT, Marks WH o Atgam induction with sequential mycophenolate mofetil for the prevention of early and late rejection in renal allograft: An 16-month experience. American Society of Transplant Surgeons, May 1997.
Bhaduri S. Florence L. Ross K. Savin V, Artero M, Vincenti F. Pre-transplant intervention to prevent recurrence of focal segmental glomerulosclerosis (FSGS) in high-risk patients. American Society of Transplant Physicians. May 1997.
Florence LS. Marks WHo Howard DR, Chapman PH, Lieberman J, Perkinson D. Atgam induction with sequential mycophenolale mofetil (MMF) decreases the incidence of early allograft rejection in cadaveric renal transplants. American Society of Transplant Physicians, May 1996.
Lieberman J. Marks WH, Stuart FP, Abecassis MM, Florence LS and Kaufman O. Co-monitoring serum anodal trypsinogen, serum amylase and serum creatinine accurately differentiates rejection from other causes of allograft dysfunction after simultaneous pancreas-kidney transplantation. American Society of Transplant Surgeons, May 1996.
Florence LS, Brennan P, Amend W, Vincenti F, Ascher N, Roberts J, Melzer J, Bretan P, Stock P, Garovoy M and Tomlanovich S. "The utility of serial CD3 measurements to predict rebound rejection atter OKT3 therapy following renal transplantation. American Society of Transplant Physicians. May 1993.